Companies: 10,793     total market cap: S$177.722 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ
Repligen
RGEN
#2608
Rank
S$8.60 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
S$152.62
Share price
0.01%
Change (1 day)
-7.26%
Change (1 year)
๐Ÿงฌ Biotech
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of December 2025 : S$0.97 Billion

According to Repligen 's latest financial reports the company has S$0.97 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$0.98 B-4.26%
2024-12-31S$1.02 B3.75%
2023-12-31S$0.99 B18.66%
2022-12-31S$0.83 B2.44%
2021-12-31S$0.81 B-13.98%
2020-12-31S$0.94 B33.21%
2019-12-31S$0.71 B169.03%
2018-12-31S$0.26 B13.94%
2017-12-31S$0.23 B13.26%
2016-12-31S$0.20 B102.11%
2015-12-31S$0.10 B31.45%
2014-12-31S$77.23 M-1.07%
2013-12-31S$78.07 M59.39%
2012-12-31S$48.98 M
2011-03-31S$62.53 M-15.78%
2010-03-31S$74.24 M0.04%
2009-03-31S$74.21 M8.09%
2008-03-31S$68.66 M100.02%
2007-03-31S$34.32 M11.75%
2006-03-31S$30.71 M7.63%
2005-03-31S$28.54 M22.42%
2004-03-31S$23.31 M-14.96%
2003-03-31S$27.41 M-28.75%
2002-03-31S$38.47 M-11.46%
2001-03-31S$43.45 M-25.7%
2000-03-31S$58.48 M926.04%
1999-03-31S$5.69 M-24.95%
1998-03-31S$7.59 M50.23%
1997-03-31S$5.05 M-47.92%
1996-03-31S$9.7 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
S$17.32 B 1,671.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$12.87 B 1,216.39%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$15.78 B 1,514.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.59 B 1,290.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$37.73 M-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.93 B-4.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.88 B 92.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.22 B-77.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.98 B 103.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$0.27 B-72.15%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com